NCT05782478 Added Diagnostic Value of Point of Care Ultrasound in Acute Dyspnea
| NCT ID | NCT05782478 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Region Skane |
| Condition | Dyspnea |
| Study Type | OBSERVATIONAL |
| Enrollment | 160 participants |
| Start Date | 2023-03-09 |
| Primary Completion | 2026-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 160 participants in total. It began in 2023-03-09 with a primary completion date of 2026-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Dyspnea is a common diagnostic challenge in the Emergency Department (ED). Delay in diagnosis will increase time to correct treatment and could impact outcome. Previous studies have shown excellent diagnostic performance of point of care ultrasound (POCUS) to detect and differentiate between several important diagnosis (e.g heart failure and pneumonia) in patients with dyspnea. However, in most studies POCUS is performed by physicians highly experienced in ultrasound and often studies have focused only on one or few diagnoses. The aim of this study is to compare the diagnostic accuracy of different diagnosis in dyspnoeic patients before and after a ED physician with limited training applies POCUS.
Eligibility Criteria
Inclusion Criteria: Adult patients presenting to the Emergency Department within the highest or second highest triage category and any of the following * Presenting with shortness of breath * Oxygen saturation less than 90 % on room air * Respiratory rate more than 25 breaths per minute and oxygen saturation less than 95 % on room air Exclusion Criteria: * Inclusion in the study will delay urgent interventions * Patient is discharge from the Emergency Department (without hospital admission)
Contact & Investigator
Jakob Lundager Forberg, PhD,MD
PRINCIPAL INVESTIGATOR
Region Skåne Sweden
Frequently Asked Questions
Who can join the NCT05782478 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Dyspnea. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05782478 currently recruiting?
Yes, NCT05782478 is actively recruiting participants. Contact the research team at jakob.lundager-forberg@skane.se for enrollment information.
Where is the NCT05782478 trial being conducted?
This trial is being conducted at Helsingborg, Sweden, Lund, Sweden.
Who is sponsoring the NCT05782478 clinical trial?
NCT05782478 is sponsored by Region Skane. The principal investigator is Jakob Lundager Forberg, PhD,MD at Region Skåne Sweden. The trial plans to enroll 160 participants.